Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer
-
* Corresponding author: Ruben Rene Gonzalez rgonzalez@msm.edu
Breast Cancer Research 2009, 11:R36 doi:10.1186/bcr2321